An FDA scientist argued yesterday that asthma sufferers should no longer use four popular asthma drugs, including GlaxoSmithKline P.L.C.'s Advair and AstraZeneca P.L.C.'s Symbicort, because they may increase the risk of death.
An FDA scientist argued yesterday that asthma sufferers should no longer use four popular asthma drugs, including GlaxoSmithKline P.L.C.'s Advair and AstraZeneca P.L.C.'s Symbicort, because they may increase the risk of death.
